Closed System Drug Transfer Device (CSTD) Market Growing at 16.3% CAGR | BD, ICU Medical, Equashield

The global Closed System Drug Transfer Device (CSTD) Market size reached USD 1,451.4 Million in 2025. Looking forward, MarketsGlob expects the market to reach USD 4,176.81 Million by 2032, exhibiting a growth rate (CAGR) of 16.3% during 2026-2032.

Market Overview:

A Closed System Drug Transfer Device (CSTD) is a specialized medical device designed to safely transfer hazardous drugs while preventing the escape of harmful vapors, aerosols, and liquid contaminants into the healthcare environment. These systems are widely used in hospitals, oncology centers, pharmacies, and healthcare facilities to reduce occupational exposure risks during the preparation and administration of chemotherapy and other hazardous drugs.

CSTDs play a critical role in protecting healthcare workers, pharmacists, nurses, and patients from exposure to toxic medications. These devices are increasingly becoming an essential component in oncology treatment centers and hospital pharmacies due to rising cancer treatment procedures and growing awareness regarding workplace safety standards.

The market is witnessing strong growth due to increasing use of hazardous drugs in cancer therapy, stricter regulatory guidelines for safe drug handling, growing healthcare infrastructure, and rising investments in oncology treatment facilities worldwide.

Key Market Drivers:

- Increasing focus on healthcare worker safety
- Rising use of hazardous drugs in cancer treatment
- Strict regulatory guidelines for drug handling
- Growing adoption in hospitals and oncology centers

The growing emphasis on contamination prevention, medication safety, and compliance with hazardous drug handling standards is further supporting demand for advanced CSTD technologies globally.

Checkout full scope of report @ https://marketsglob.com/report/closed-system-drug-transfer-device-cstd-market/306/

Recent Industry Developments:

The Closed System Drug Transfer Device (CSTD) industry has witnessed several product developments and expansion initiatives in recent years:

In 2025, ICU Medical Inc. continued expanding its ChemoLockTM and DianaTM hazardous drug preparation systems, designed to improve medication safety and reduce healthcare worker exposure during chemotherapy drug handling.

In April 2025, Becton, Dickinson and Company (BD) strengthened its medication management and hazardous drug safety portfolio through continued expansion of advanced pharmacy automation and drug preparation technologies supporting oncology safety applications.

In 2025, BD continued expanding adoption of its BD PhaSealTM Closed System Drug Transfer Device (CSTD) systems widely used in hospitals and oncology centers for safer handling of hazardous drugs and chemotherapy preparation.

In 2025, BD expanded its BD PhaSealTM Optima System product portfolio supporting preparation and administration of hazardous drugs in healthcare environments.

In 2025, Equashield LLC expanded adoption of its EQUASHIELD® II CSTD system across oncology treatment centers, focusing on contamination prevention, vapor containment, and healthcare worker safety.

In 2025, Baxter International Inc. continued strengthening oncology drug preparation and infusion technologies supporting hazardous drug handling and medication delivery systems.

In 2025, B. Braun Melsungen AG expanded advanced infusion therapy and oncology drug administration solutions supporting safer chemotherapy preparation and handling processes.

In 2025, Yukon Medical LLC continued expanding hazardous drug compounding and medication safety solutions supporting hospital pharmacy operations and oncology treatment facilities.

In 2025, Corvida Medical strengthened closed-system medication transfer technologies designed to reduce exposure risks during hazardous drug preparation and administration.

In 2025, JMS Co. Ltd. expanded infusion and oncology-related medical device solutions supporting safe medication transfer and contamination prevention applications.

These developments highlight the growing importance of hazardous drug safety systems, contamination prevention technologies, and advanced oncology medication handling solutions across hospitals and healthcare facilities worldwide.

Market Outlook:

The market is expected to witness rapid growth driven by increasing cancer incidence, expanding oncology infrastructure, rising healthcare safety awareness, and growing implementation of hazardous drug handling regulations worldwide.

Increasing adoption of chemotherapy treatments, expansion of hospital pharmacy automation, and rising investments in healthcare worker protection technologies are expected to create substantial growth opportunities for CSTD manufacturers during the forecast period.

The growing focus on contamination prevention, regulatory compliance, occupational safety, and advanced drug administration technologies is expected to further support long-term market expansion.

Competitive Landscape:

Major companies operating in the market include:

- Becton, Dickinson and Company
- Caragen Ltd
- Baxter International Inc.
- B. Braun Melsungen AG
- ICU Medical Inc.
- Corvida Medical
- JMS Co. Ltd.
- Equashield LLC
- Yukon Medical LLC
- Others

Companies are focusing on hazardous drug containment technologies, contamination prevention systems, oncology safety solutions, infusion therapy advancements, and pharmacy automation technologies to strengthen their market position globally.

Segment Analysis:

By Product Type
- Closed Vial Access Devices
- Closed Syringe Safety Devices
- Closed Bag/Line Access Devices

By Application
- Hospitals
- Oncology Clinics and Oncology Centers
- Others

By Sales Channel
- Direct Channel
- Distribution Channel

Regional Analysis

Market segment by Region/Country including:

- North America (United States, Canada, Mexico)
- Europe (Germany, United Kingdom, France, Italy, Russia, Spain, Benelux, Poland, Austria, Portugal, Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, Australia, Taiwan, Rest of Asia Pacific)
- South America (Brazil, Argentina, Colombia, Chile, Peru, Venezuela, Rest of South America)
- Middle East & Africa (UAE, Saudi Arabia, South Africa, Egypt, Nigeria, Rest of Middle East & Africa)

Get the sample of this report @ https://marketsglob.com/request-sample/?id=306

North America: Strong market growth supported by advanced oncology infrastructure, strict healthcare safety regulations, and widespread adoption of hazardous drug handling technologies.

Europe: Increasing demand driven by regulatory compliance requirements, growing cancer treatment facilities, and expanding hospital safety initiatives.

Asia-Pacific: Rapid market expansion supported by healthcare infrastructure development, increasing cancer incidence, and rising awareness regarding occupational safety.

South America and Middle East & Africa: Emerging opportunities supported by improving healthcare systems and expanding oncology treatment services.

Summary of the Research:

Chapter 1 - Market Overview: Definition, market size analysis, segmentation, and key dynamics of the Closed System Drug Transfer Device (CSTD) industry

Chapter 2 - Executive Summary: Market snapshot, key findings, and growth opportunities

Chapter 3 - Competitive Landscape: Market share analysis, pricing trends, and competitive positioning of leading players including BD, ICU Medical Inc., and Equashield LLC

Chapter 4 - Segmentation by Type: Closed Vial Access Devices, Closed Syringe Safety Devices, Closed Bag/Line Access Devices

Chapter 5 - Segmentation by Application: Hospitals, Oncology Clinics and Oncology Centers, Others

Chapter 6 - Segmentation by Sales Channel: Direct channel and distribution channel

Chapter 7 - Regional Analysis: Country-level insights across North America, Europe, Asia-Pacific, South America, and Middle East & Africa

Chapter 8 - Company Profiles: Detailed analysis of leading companies including Baxter International Inc., B. Braun Melsungen AG, and Yukon Medical LLC

Chapter 9 - Supply Chain Analysis: Medical device components, hazardous drug systems, hospital pharmacy applications, and downstream healthcare services

Chapter 10 - Industry Analysis: Porter's Five Forces and overall oncology safety ecosystem analysis

Chapter 11 - Forecast Analysis: Market projections and future growth trends through the forecast period

Chapter 12 - Import-Export Analysis: Global trade trends and regional medical device movement analysis

Chapter 13 - Demand-Supply Gap Analysis: Healthcare demand, manufacturing capacity, and market balance assessment

Chapter 14 - Appendix: Research methodology and data sources

In-detail ToC @ https://marketsglob.com/report/closed-system-drug-transfer-device-cstd-market/306/toc/

Research Methodology:

The report is developed using a combination of primary and secondary research methodologies. Primary research includes interviews with hospital administrators, oncology specialists, pharmacists, medical device manufacturers, and healthcare industry participants. Secondary research includes company reports, healthcare publications, oncology journals, medical databases, and verified industry sources. Market forecasting is conducted through historical trend analysis, healthcare infrastructure assessment, oncology treatment demand evaluation, and analysis of regulatory developments across global healthcare systems.

Market Perspective

The Closed System Drug Transfer Device (CSTD) Market is experiencing strong growth supported by increasing focus on healthcare worker safety, expanding oncology treatment infrastructure, and rising implementation of hazardous drug handling regulations worldwide.

Growing investments in hospital pharmacy automation, contamination prevention technologies, and oncology safety systems are expected to continue driving market expansion globally. With continued advancements in hazardous drug containment technologies, medication safety systems, and healthcare compliance standards, the market is expected to remain a critical segment within the global medical device and oncology safety industry.

Contact us:
Jaysn Sahu
Corporate Sales Specialist
Email: jaysn.s@marketsglob.com
Phone: +1 (210) 807 3402

MarketsGlob is a global market research firm providing reliable and expert insights trusted by leading industries. The company delivers detailed reports on market trends, technological advancements, and industry developments, helping businesses make informed decisions and improve their strategies.

This release was published on openPR.